Rapid Syndromic Testing for All Labs The mission of iCubate® is to provide rapid, accurate and affordable syndromic testing to all laboratories to ensure care providers have the right tools to improve care and outcomes for their patients. The iCubate® team has developed the iC System™, a low-cost, fully automated, molecular diagnostic platform using armPCR technology, along with a suite of syndromic infectious diseases panels, including sepsis/positive blood cultures, upper / lower respiratory tract infections, GI, mycobacteria, and more. Why iCubate for your lab? • Rapid syndromic testing for infectious diseases for better care, sooner • Affordable system increasing accessibility for large and small labs • Multiplex assay with high target specificity and sensitivity for actionable results • 3 minutes of hands-on time with routine lab processes Twitter: @iCubate FDA Cleared Products iC-System™ (iCubate’s platform) iC-GPC Assay™ for Gram positive cocci Anticipated clearance 2019 iC-GN Assay™ for Gram negative rods Robust Assay Pipeline GI, Respiratory, Mycobacterium
